Stock listing
Frankfurt:BM8 BioMarin Pharmaceutical Inc. Aktie
German listing (Frankfurt) of BioMarin Pharmaceutical Inc. · home listing NASDAQ:BMRN
Follow BioMarin Pharmaceutical Inc. into a list and get an email when it puts out news.
Share price · FWB:BM8
€52.02 EUR +2.04 (+4.1%)
Close on Oct 30, 2026
- Day range
- €51.30 – €52.02 EUROct 30, 2026
- Market cap
- €10.07B EURAt the close on Oct 30, 2026 · price × 193.6M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BMRN · Home | $58.51 USD | +1.02 (+1.8%) | 2,273,535 | $58.39 | $59.37 | $57.86 | $57.49 | Close on Oct 30, 2026 |
| Frankfurt:BM8 | €52.02 EUR | +2.04 (+4.1%) | — | €51.30 | €52.02 | €51.30 | €49.98 | Close on Oct 30, 2026 |
| B3:B1MR34 | 144.05 BRL | 0.00 (0.0%) | — | 144.05 | 144.05 | 144.05 | 144.05 | Close on Oct 21, 2026 |
| LSE:0HNC | $55.46 USD | -0.18 (-0.3%) | 4,452 | $56.00 | $56.04 | $55.46 | $55.64 | Close on Oct 27, 2026 |
| Munich:BM8 | €50.35 EUR | -0.02 (0.0%) | — | €50.35 | €50.35 | €50.35 | €50.37 | Close on Oct 27, 2026 |
- Ticker
- Frankfurt:BM8
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 29, 2026
BioMarin Enters Into Exclusive Worldwide License Agreement With GC Biopharma and Hanmi Pharm for Investigational Next-Generation Enzyme Replacement Therapy, Adding a Second Potential Treatment for Fabry Disease
Latest earnings call · Aug 6, 2026
BioMarin Pharmaceutical (NASDAQ:BMRN) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 6, 2026
Q2 2026 Earnings Presentation
Earnings · 28 slides
Calls
Upcoming
BioMarin Pharmaceutical (NASDAQ:BMRN) Q3 2026 Earnings Call
Mon, Nov 02, 2026 · 4:30 PM ET
Register
Replays
BioMarin Pharmaceutical (NASDAQ:BMRN) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 4:30 PM ET
Watch TranscriptBioMarin Pharmaceutical (NASDAQ:BMRN) Q1 2026 Earnings Call
Mon, May 04, 2026 · 4:30 PM ET
Watch TranscriptBioMarin Pharmaceutical (NASDAQ:BMRN) Q4 2025 Earnings Call
Mon, Feb 23, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Decks
Q2 2026 Earnings Presentation
Earnings · 28 slides · Aug 6, 2026
Q1 2026 Earnings Presentation
Earnings · 21 slides · May 4, 2026
Q4 2025 Earnings Presentation
Earnings · 22 slides · Feb 23, 2026
44th Annual J.P. Morgan Healthcare Conference (January 2026)
Conference · 26 slides · Jan 12, 2026
BioMarin Pharmaceutical Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 38 in the last 12 months · 239 in all · newest Oct 29, 2026 · oldest 2019
- Calls
- 23 calls with a replay · 23 with a transcript · latest Aug 6, 2026
- Decks
- 53 decks · latest Aug 6, 2026
Where BioMarin Pharmaceutical Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BMRN · Home listing | NASDAQ | United States | USD |
| gettex:BM8 | gettex | Germany | EUR |
| Tradegate:BM8 | Tradegate | Germany | EUR |
| LS Exchange:924801 | LS Exchange | Germany | EUR |
| Frankfurt:BM8 · This page | Frankfurt | Germany | EUR |
| BMV:BMRN | BMV | Mexico | MXN |
| Lang & Schwarz:924801 | Lang & Schwarz | Germany | EUR |
| B3:B1MR34 | B3 | Brazil | BRL |
| LSE:0HNC | LSE | United Kingdom | USD |
| Milan:1BMRN | Milan | Italy | EUR |
| BX Swiss:BM8 | BX Swiss | Switzerland | CHF |
| EUROTLX:4BMRN | EUROTLX | Italy | EUR |
| Munich:BM8 | Munich | Germany | EUR |
| VIE:BMRN | Vienna | Austria | EUR |
| BOATS:BMRN | BOATS | United States | USD |
| Dusseldorf:BM8 | Dusseldorf | Germany | EUR |
| Hamburg:BM8 | Hamburg | Germany | EUR |
| Hanover:BM8 | Hanover | Germany | EUR |
| Stuttgart:BM8 | Stuttgart | Germany | EUR |
| BIVA:BMRN | BIVA | Mexico | MXN |
Log in to ask 6ix AI your own questions about BioMarin Pharmaceutical Inc.